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Laboratory criteria for severe Crimean-Congo haemorrhagic fever
Mesut ORTATATLI1, Serdar Ümit SARICI2

We have read with great interest the article entitled “Evaluation of the tick bites in a CrimeanCongo haemorrhagic fever (CCHF) endemic area in Turkey”, which reviews tick bites in an endemic
area of CCHF in Turkey and has been published in the Turkish Journal of Medical Sciences 2011;
41 (1): 131-136 (1). However, we have some concerns and criticisms regarding the methods and
analysis of the data of the article.
In Materials and Methods it is stated that questions concerning demographic information,
the location where the subject acquired the tick, occupation of the subject, admission date,
the anatomical site of the bite, exposure prone activity, the date of the bite (if known), possible
duration of tick attachment, and tick removal procedures were recorded. However, detailed
descriptions about how the patients were followed with which clinical and laboratory parameters
would have been more useful regarding reproducibility and as a guide for future studies about
this issue. With this aim clinical and laboratory description criteria suggested for CCHF (fever,
headache with a sudden onset, myalgia/arthralgia, fatigue, emesis/vomiting, abdominal pain/
diarrhea in anamnesis of the patients and leucopenia, thrombocytopenia, elevations in aspartate
aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LDH) and
creatine phosphokinase (CPK) as laboratory parameters) might have been used (2).
Two patients with CCHF are discussed in Results and Discussion. It is stated that these patients
had mild clinical and laboratory symptoms thus not requiring ribavirin treatment. However,
a standard method for the follow up of such patients as previously described as the criteria of
severe disease might have been given (Table) (3). Moreover, detailed numeric values of laboratory
measurements (extents of leukopenia, thrombocytopenia, elevated serum ALT, and CPK levels)
would have been, if given, more appropriate to inform the readers.
Table. Criteria of severe disease (3).
An activated partial thromboplastin time (aPTT) longer than 60 s.
Elevated prothrombin time (PT)
A platelet count below 20,000/mm3
An AST level over 700 U/L
An ALT level over 900 U/L
A fibrinogen level below 110 mg/dL
Melena
Hematemesis
Somnolence
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In the Results section 2 patients with CCHF are
mentioned, one of whom is a 46-year-old male who
had removed the tick from his leg with tweezers and
the other is a 23-year-old female who had removed
the tick herself. However, in the Discussion section
the same 2 cases (with CCHF) are described as a
49-year-old male who had removed the tick himself
by crushing it, and a 76-year-old male whose tick had
been removed by a physician. This discrepancy in the
sections of Results and Discussion decreases the value
of the study, which is deserving of praise.

In our particular conclusion, patients with tick
exposure should be informed about the course
of CCHF, and they should be strongly advised to
present to an emergency health care department in
the event of fever, sudden onset of headache, myalgia/
arthralgia, fatigue, emesis/vomiting, and abdominal
pain/diarrhea. Hemoglobin level, white blood cell
and platelet counts, and levels of AST, ALT, LDH,
CPK, PT, and aPTT should be measured during the
follow up of these cases (1-3).
With our best regards,
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Author’s Response
Serpil EROL

We have read Drs. Ortatatlı and Sarıcı letter
about our article. As we stated in the article, the aim
of our study was to evaluate tick bites and their role
in the occurrence of Crimean-Congo hemorrhagic
fever (CCHF) in an endemic region, rather than to
evaluate clinical features of the disease. All the cases
were followed for 10 days for occurrence of CCHF
by clinical signs and laboratory findings. As the
authors have expressed clearly in their letter, clinical
and laboratory description criteria for CCHF were:
fever, headache of acute onset, myalgia/arthralgia,
fatigue, emesis/vomiting, abdominal pain/diarrhea,
leucopenia, thrombocytopenia, elevations in aspartate
aminotransferase (AST), alanine aminotransferase
(ALT), lactate dehydrogenase (LDH), and creatine
phosphokinase (CK). All patients were evaluated
for these parameters at admission and thereafter
once every 3 days for 10 days. In the patients who
had one or more clinical or laboratory findings, the
diagnosis of CCHF was confirmed by the presence
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Ergonul O, Celikbas A, Baykam N, Eren S, Dokuzoguz B.
Analysis of risk-factors among patiens with Crimean-Congo
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of anti-CCHF-IgM antibody by ELISA and/or
CCHF-RNA by reverse transcriptase-polymerase
chain reaction (RT-PCR) in the serum samples.
The two patients who presented with CCHF had no
hemorrhagic manifestations, somnolence, or severe
thrombocytopenia requiring platelet replacement.
Their ALT and AST values were <350 U/L, LDH
<300 U/L, CK<350 U/L, and platelet counts were
>40,000/mm3. The lowest leucocyte count was 2200/
mm3. The patients also did not need blood or blood
products replacement. All clinical symptoms and
findings resolved spontaneously in days. Therefore,
their clinical status was considered mild. The
discrepancy in the sections of Results and Discussion
concerning patient information is a typing error and
the correct one is in the Results section. I think the
error occurred during the removal of a part of the
text in a previous version of the manuscript.
As the authors indicate in their conclusion, all
patients with tick exposure should be evaluated
clinically and with laboratory tests at admission and
informed about the course of CCHF. They should be
advised to present to a health care facility in the event
of the presence any sign or symptom of the disease.
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